Testing for C. difficile is indicated in patients with diarrhea, especially after antibiotic use or healthcare exposure.

In animal models, this first mRNA-LNP C. difficile vaccine was found to protect against C. difficile first-time infections ...

Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.

“C. diff is a really challenging pathogen,” said lead author Joseph Zackular, assistant professor of pathology and laboratory medicine at Penn. “This vaccine is kind of a really nice proof of ...

The panelist discusses how antibiotics are paradoxically both the primary treatment for Clostridioides difficile infections ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

Research has shown bleaches used in hospital are not effective against C. diff One of the main types of disinfectant used to clean hospital scrubs and surfaces does not work against a common ...